A new clinical trial using famotidine — an ingredient in the over-the-counter drug Pepcid — may help provide a treatment for COVID-19. Dr. Kevin Tracey, president of Feinstein Institutes for Medical Research at Northwell Health, has so far enrolled 187 patients in the trial.
Tracey said he got the idea after news out of China indicated people taking the drug did better than those who weren’t. However, he cautioned people not to run to the store in an attempt to start treating themselves with the drug, as there is no evidence yet that it even works. Plus, the patients in the trial are in the hospital getting megadoses of it intravenously — about nine times more than a normal dose.
Source: MSN Lifestyle April 27, 2020